NEOG NEOGEN CORP
Healthcare · In Vitro & In Vivo Diagnostic Substances · Market cap: $2.5B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $50.1K | $120.0K |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $1.1M | $0 |
| 2022-Q4 | $85.9K | $0 |
| 2023-Q1 | $44.8K | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $33.9K |
| 2023-Q4 | $379.7K | $75.8K |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $662.2K | $0 |
| 2024-Q3 | $50.6K | $0 |
| 2024-Q4 | $200.1K | $0 |
| 2025-Q1 | $418.5K | $0 |
| 2025-Q2 | $771.8K | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $1.1K | $0 |
| 2026-Q1 | $2.0K | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $4.4K | $0 |
| 2026-Q4 | $6.0K | $114.7K |
Bought$3.7M39 buy days
Sold$372.9K7 sell days
Net insider flow+$3.4Mnet buying · 5 years
Latest trade2026-11-04Yarwood Jeremy
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-04 | Sell | Yarwood Jeremy | Other C-suite | 9,051 | $12.67 | $114.7K | 1 |
| 2026-10-09 | Buy | Nassif Mikheal | CEO | 505 | $11.95 | $6.0K | 1 |
| 2026-08-04 | Buy | Nassif Mikheal | CEO | 370 | $11.81 | $4.4K | 1 |
| 2026-02-17 | Buy | Nassif Mikheal | CEO | 23 | $10.94 | $252 | 1 |
| 2026-02-02 | Buy | Nassif Mikheal | CEO | 24 | $10.00 | $240 | 1 |
| 2026-01-26 | Buy | Nassif Mikheal | CEO | 25 | $9.86 | $246 | 1 |
| 2026-01-16 | Buy | Nassif Mikheal | CEO | 137 | $9.33 | $1.3K | 1 |
| 2025-11-03 | Buy | Nassif Mikheal | CEO | 177 | $6.25 | $1.1K | 1 |
| 2025-05-12 | Buy | Gupta Aashima | Director | 16,000 | $6.25 | $100.0K | 1 |
| 2025-04-25 | Buy | Woteki Catherine E | Director | 5,770 | $5.17 | $29.8K | 1 |
| 2025-04-24 | Buy | BOREL JAMES C | Director | 65,000 | $4.94 | $320.8K | 2 |
| 2025-04-24 | Buy | BOEHM WILLIAM T | Director | 5,000 | $5.24 | $26.2K | 1 |
| 2025-04-23 | Buy | Rocklin Amy M | Other C-suite | 12,500 | $4.99 | $62.4K | 1 |
| 2025-04-22 | Buy | CAPELLO JEFFREY D | Director | 20,712 | $4.84 | $100.2K | 1 |
| 2025-04-22 | Buy | Tobin James P | Director | 10,000 | $4.73 | $47.3K | 1 |
| 2025-04-22 | Buy | RODRIGUEZ RAFAEL A | Director | 7,474 | $4.59 | $34.3K | 1 |
| 2025-04-10 | Buy | Moylan John Patrick | Other C-suite | 10,000 | $5.07 | $50.7K | 1 |
| 2025-01-16 | Buy | ADENT JOHN EDWARD | CEO | 23,035 | $11.03 | $254.1K | 1 |
| 2025-01-16 | Buy | Naemura David H. | CFO | 14,800 | $11.11 | $164.4K | 1 |
| 2024-10-11 | Buy | ADENT JOHN EDWARD | CEO | 14,500 | $13.80 | $200.1K | 1 |
| 2024-08-06 | Buy | Tobin James P | Director | 3,000 | $16.86 | $50.6K | 1 |
| 2024-04-17 | Buy | Jones Douglas Edward | COO | 10,000 | $12.36 | $123.6K | 1 |
| 2024-04-11 | Buy | BOREL JAMES C | Director | 7,500 | $13.06 | $98.0K | 1 |
| 2024-04-10 | Buy | ADENT JOHN EDWARD | CEO | 23,000 | $12.36 | $284.3K | 1 |
| 2024-04-10 | Buy | Naemura David H. | CFO | 12,500 | $12.51 | $156.4K | 1 |
| 2023-11-03 | Buy | BOEHM WILLIAM T | Director | 2,000 | $16.06 | $32.1K | 1 |
| 2023-10-25 | Buy | Jones Douglas Edward | COO | 10,000 | $15.17 | $151.7K | 1 |
| 2023-10-13 | Sell | Lilly Jason Warren | VP | 351 | $15.10 | $5.3K | 1 |
| 2023-10-12 | Buy | Tobin James P | Director | 3,000 | $15.19 | $45.6K | 1 |
| 2023-10-11 | Buy | Naemura David H. | CFO | 10,000 | $15.03 | $150.3K | 1 |
| 2023-10-11 | Sell | BOEHM WILLIAM T | Director | 2,591 | $15.61 | $40.4K | 1 |
| 2023-10-11 | Sell | Lilly Jason Warren | VP | 1,917 | $15.69 | $30.1K | 1 |
| 2023-08-18 | Sell | BOEHM WILLIAM T | Director | 1,500 | $22.59 | $33.9K | 1 |
| 2023-01-13 | Buy | Jones Douglas Edward | COO | 2,500 | $17.91 | $44.8K | 1 |
| 2022-10-11 | Buy | Quinlan Steven J. | CFO | 5,000 | $11.63 | $58.2K | 1 |
| 2022-10-03 | Buy | BOEHM WILLIAM T | Director | 2,000 | $13.89 | $27.8K | 1 |
| 2022-09-28 | Buy | ADENT JOHN EDWARD | CEO | 22,000 | $14.37 | $316.1K | 1 |
| 2022-09-28 | Buy | Jones Douglas Edward | COO | 7,000 | $14.31 | $100.2K | 1 |
| 2022-08-16 | Buy | Vetter Darci L | Director | 1,100 | $21.83 | $24.0K | 1 |
| 2022-08-02 | Buy | Green Ronald D | Director | 1,500 | $22.50 | $33.8K | 1 |
| 2022-07-29 | Buy | ADENT JOHN EDWARD | CEO | 17,500 | $23.07 | $403.7K | 1 |
| 2022-07-27 | Buy | BOREL JAMES C | Director | 6,500 | $22.70 | $147.6K | 1 |
| 2022-07-27 | Buy | Tobin James P | Director | 2,000 | $22.98 | $46.0K | 1 |
| 2022-01-25 | Buy | Jones Douglas Edward | Other C-suite | 1,400 | $35.78 | $50.1K | 1 |
| 2022-01-12 | Sell | BOEHM WILLIAM T | Director | 3,000 | $40.00 | $120.0K | 1 |
| 2021-12-23 | Sell | Lilly Jason Warren | VP | 636 | $44.91 | $28.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| ADENT JOHN EDWARD | CEO | $1.5M | $0 | 2025-01-16 |
| BOREL JAMES C | Director | $566.4K | $0 | 2025-04-24 |
| Naemura David H. | CFO | $471.1K | $0 | 2025-01-16 |
| Jones Douglas Edward | COO | $470.3K | $0 | 2024-04-17 |
| BOEHM WILLIAM T | Director | $86.1K | $194.3K | 2025-04-24 |
| Tobin James P | Director | $189.4K | $0 | 2025-04-22 |
| Yarwood Jeremy | Other C-suite | $0 | $114.7K | 2026-11-04 |
| CAPELLO JEFFREY D | Director | $100.2K | $0 | 2025-04-22 |
| Gupta Aashima | Director | $100.0K | $0 | 2025-05-12 |
| Lilly Jason Warren | VP | $0 | $63.9K | 2023-10-13 |
| Rocklin Amy M | Other C-suite | $62.4K | $0 | 2025-04-23 |
| Quinlan Steven J. | CFO | $58.2K | $0 | 2022-10-11 |
| Moylan John Patrick | Other C-suite | $50.7K | $0 | 2025-04-10 |
| RODRIGUEZ RAFAEL A | Director | $34.3K | $0 | 2025-04-22 |
| Green Ronald D | Director | $33.8K | $0 | 2022-08-02 |
| Woteki Catherine E | Director | $29.8K | $0 | 2025-04-25 |
| Vetter Darci L | Director | $24.0K | $0 | 2022-08-16 |
| Nassif Mikheal | CEO | $13.5K | $0 | 2026-10-09 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-04-10 → 2025-05-12 | 9 | $771.8K | 57 | +19.0% (+24.3% raw) | -13.4% (+2.8% raw) | -3.5% (+23.3% raw) | closed |
| 2024-04-10 → 2024-04-17 | 4 | $662.2K | 64 | -1.3% (0.0% raw) | +20.5% (+30.0% raw) | -1.0% (+12.4% raw) | closed |
| 2023-10-11 → 2023-11-03 | 4 | $379.7K | 49 | +1.1% (+10.2% raw) | -12.5% (+5.9% raw) | -41.8% (-18.4% raw) | closed |
| 2022-09-28 → 2022-10-11 | 4 | $502.2K | 60 | -10.7% (-9.1% raw) | +12.1% (+12.7% raw) | +18.4% (+19.5% raw) | closed |
| 2022-07-27 → 2022-08-16 | 5 | $655.0K | 62 | -16.2% (-20.8% raw) | -30.1% (-39.2% raw) | -8.0% (-7.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.